PhaseV's New Model Provides Insights into GLP-1 Treatment Outcomes Based on Real-World Data #USA #Boston #PhaseV #Veradigm #GLP-1

PhaseV Strengthens Leadership with Biopharma Experts Klaus Beck and Avi Kulkarni for AI Development #United_States #Boston #PhaseV #Avi_Kulkarni #Klaus_Beck